// App-Quantinova.ai

15629 : A Prospective Placebo Controlled Randomized Study of Caffeine in Patients With Supraventricular Tachycardia Undergoing Electrophysiological Testing. I. Effects on Cardiac Conduction and Refractoriness

Researchers

Presenter

  • Amanda Pecarskie

Principal Investigators

  • Kathryn Williams

  • George A Wells

Medical Centers

  • University of Ottawa Heart Institute, Ottawa, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Arrhythmia

Biomarkers

  • N/A

Drug/Treatment

  • Caffeine

Outcome

  • N/A


Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim